Predictors of Medow et al for Patients with Squamous Cell Carcinoma of the Head and Neck

Description

Medow et al correlated survival in patients with squamous cell carcinoma of the head and neck with 3 simple predictors. This can help identify patients with poor survival who may require more aggressive therapy. The authors are from the Arthur James Cancer Hospital at the Ohio State University.

Parameters:

(1) TNM stage

(2) serum albumin

(3) age of the patient

Scheme 1: TNM stage and Serum Albumin

TNM Stage	Serum Albumin	Median Survival
I, II or III	NA	1,068 days
IV or recurrent	>= 3.85 g/dL	625 days
IV or recurrent	< 3.85 g/dL	404 days

from Figure 2, page 1284

Scheme 2: TNM stage and Age of the Patient in Years

TNM Stage	Age in Years	Median Survival
I, II or III	NA	1,068 days
IV or recurrent	< 66.5	687 days
IV or recurrent	>= 66.5	409 days

from Figure 3, page 1285

To read more or access our algorithms and calculators, please log in or register.

Predictors of Medow et al for Patients with Squamous Cell Carcinoma of the Head and Neck

Description

Specialty